Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%-.--%-6.03x3.55x8.18x-5x-4.74x 2.07TCr
0.64%0.72%15.92x1.85x3.44x9.29x10.17x 6.26TCr
0.57%0.58%27.98x4.17x5.65x16.18x20.82x 5.72TCr
-.--%-.--%32.93x6.64x11.14x21.01x24.87x 4.08TCr
3.81%3.91%-48.08x2.19x2.93x8.66x10.11x 3.63TCr
-.--%-.--%32.07x1.48x3.48x10.5x12.45x 2.93TCr
-.--%-.--%15.54x3.03x2.73x8.46x8.27x 2.04TCr
-.--%0.06%49.72x4.95x5.3x38.06x34.68x 1.72TCr
-.--%-.--%24.35x3.41x5.04x13.6x18.93x 1.6TCr
-.--%-.--%-31.26x-5.42x14.74x-44.61x-46.38x 1.33TCr
-.--%-.--%-131.05x13421.61x13.12x-116.24x-131.16x 1.3TCr
0.15%0.15%63.85x26.18x40.01x56.2x57.86x 1.24TCr
-.--%-.--%15.8x - 3.4x12.48x14.95x 1.08TCr
-.--%-.--%41.66x - - - - 957.36Cr
2.81%3.25%11.99x1.04x1.82x7.34x9.78x 644.57Cr
1.66%1.84%13.44x1.25x2.34x6.06x7.29x 545.81Cr
-.--%-.--%-107.75x - - - - 529.81Cr
0.42%0.5%24.32x - 6.44x17.08x20.39x 496.87Cr
Average 0.56% 0.61% 2.52x 962.57x 8.11x 3.69x 4.27x 2.12TCr
Weighted average by Cap. 0.63% 0.67% 9.19x 502.19x 6.96x 7.66x 8.98x
Biopharmaceuticals
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!